Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-30

Clinical Trial Update: The Inflammatory Profile of Exacerbations in Patients With Severe Asthma Receiving Tezepelumab: The TezEx Study

View source ↗

Summary

A clinical study assessing the inflammatory profile of exacerbations in severe asthma patients treated with tezepelumab (Tezspire); the study is not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tezspire (tezepelumab)

Snippet

Sponsor: Guy's and St Thomas' NHS Foundation Trust | Conditions: Severe Asthma | Status: NOT_YET_RECRUITING